Family history assessment: Impact on disease risk perceptions

Catharine Wang, Ananda Sen, Mack Ruffin, Donald E. Nease, Robert Gramling, Louise S. Acheson, Suzanne M. O'Neill, Wendy S. Rubinstein

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Background: Family Healthware™, a tool developed by the CDC, is a self-administered web-based family history tool that assesses familial risk for six diseases (coronary heart disease; stroke; diabetes; and colon, breast, and ovarian cancers) and provides personalized prevention messages based on risk. The Family Healthware Impact Trial (FHITr) set out to examine the clinical utility of presenting personalized preventive messages tailored to family history risk for improving health behaviors. Purpose: The purpose of this study was to examine the impact of Family Healthware on modifying disease risk perceptions, particularly among those who initially underestimated their risk for certain diseases. Design: A total of 3786 patients were enrolled in a cluster-randomized trial to evaluate the clinical utility of Family Healthware. Setting/participants: Participants were recruited from 41 primary care practices among 13 states between 2005 and 2007. Main outcome measures: Perceived risk for each disease was assessed at baseline and 6-month follow-up using a single-item comparative risk question. Analyses were completed in March 2012. Results: Compared to controls, Family Healthware increased risk perceptions among those who underestimated their risk for heart disease (15% vs 9%, p<0.005); stroke (11% vs 8%, p<0.05); diabetes (18% vs 11%, p<0.05); and colon cancer (17% vs 10%, p=0.05) but not breast or ovarian cancers. The majority of underestimators did not shift in their disease risk perceptions. Conclusions: Family Healthware was effective at increasing disease risk perceptions, particularly for metabolic conditions, among those who underestimated their risk. Results from this study also demonstrate the relatively resistant nature of risk perceptions. Trial registration: This study is registered at clinicaltrials.gov NCT00164658.

Original languageEnglish (US)
Pages (from-to)392-398
Number of pages7
JournalAmerican Journal of Preventive Medicine
Volume43
Issue number4
DOIs
StatePublished - Oct 1 2012

Fingerprint

Ovarian Neoplasms
Colonic Neoplasms
Stroke
Breast Neoplasms
Health Behavior
Centers for Disease Control and Prevention (U.S.)
Coronary Disease
Heart Diseases
Primary Health Care
Outcome Assessment (Health Care)

All Science Journal Classification (ASJC) codes

  • Epidemiology
  • Public Health, Environmental and Occupational Health

Cite this

Wang, C., Sen, A., Ruffin, M., Nease, D. E., Gramling, R., Acheson, L. S., ... Rubinstein, W. S. (2012). Family history assessment: Impact on disease risk perceptions. American Journal of Preventive Medicine, 43(4), 392-398. https://doi.org/10.1016/j.amepre.2012.06.013
Wang, Catharine ; Sen, Ananda ; Ruffin, Mack ; Nease, Donald E. ; Gramling, Robert ; Acheson, Louise S. ; O'Neill, Suzanne M. ; Rubinstein, Wendy S. / Family history assessment : Impact on disease risk perceptions. In: American Journal of Preventive Medicine. 2012 ; Vol. 43, No. 4. pp. 392-398.
@article{fb0e131c475b48fa89b9ddcdbb9a3bb9,
title = "Family history assessment: Impact on disease risk perceptions",
abstract = "Background: Family Healthware™, a tool developed by the CDC, is a self-administered web-based family history tool that assesses familial risk for six diseases (coronary heart disease; stroke; diabetes; and colon, breast, and ovarian cancers) and provides personalized prevention messages based on risk. The Family Healthware Impact Trial (FHITr) set out to examine the clinical utility of presenting personalized preventive messages tailored to family history risk for improving health behaviors. Purpose: The purpose of this study was to examine the impact of Family Healthware on modifying disease risk perceptions, particularly among those who initially underestimated their risk for certain diseases. Design: A total of 3786 patients were enrolled in a cluster-randomized trial to evaluate the clinical utility of Family Healthware. Setting/participants: Participants were recruited from 41 primary care practices among 13 states between 2005 and 2007. Main outcome measures: Perceived risk for each disease was assessed at baseline and 6-month follow-up using a single-item comparative risk question. Analyses were completed in March 2012. Results: Compared to controls, Family Healthware increased risk perceptions among those who underestimated their risk for heart disease (15{\%} vs 9{\%}, p<0.005); stroke (11{\%} vs 8{\%}, p<0.05); diabetes (18{\%} vs 11{\%}, p<0.05); and colon cancer (17{\%} vs 10{\%}, p=0.05) but not breast or ovarian cancers. The majority of underestimators did not shift in their disease risk perceptions. Conclusions: Family Healthware was effective at increasing disease risk perceptions, particularly for metabolic conditions, among those who underestimated their risk. Results from this study also demonstrate the relatively resistant nature of risk perceptions. Trial registration: This study is registered at clinicaltrials.gov NCT00164658.",
author = "Catharine Wang and Ananda Sen and Mack Ruffin and Nease, {Donald E.} and Robert Gramling and Acheson, {Louise S.} and O'Neill, {Suzanne M.} and Rubinstein, {Wendy S.}",
year = "2012",
month = "10",
day = "1",
doi = "10.1016/j.amepre.2012.06.013",
language = "English (US)",
volume = "43",
pages = "392--398",
journal = "American Journal of Preventive Medicine",
issn = "0749-3797",
publisher = "Elsevier Inc.",
number = "4",

}

Wang, C, Sen, A, Ruffin, M, Nease, DE, Gramling, R, Acheson, LS, O'Neill, SM & Rubinstein, WS 2012, 'Family history assessment: Impact on disease risk perceptions', American Journal of Preventive Medicine, vol. 43, no. 4, pp. 392-398. https://doi.org/10.1016/j.amepre.2012.06.013

Family history assessment : Impact on disease risk perceptions. / Wang, Catharine; Sen, Ananda; Ruffin, Mack; Nease, Donald E.; Gramling, Robert; Acheson, Louise S.; O'Neill, Suzanne M.; Rubinstein, Wendy S.

In: American Journal of Preventive Medicine, Vol. 43, No. 4, 01.10.2012, p. 392-398.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Family history assessment

T2 - Impact on disease risk perceptions

AU - Wang, Catharine

AU - Sen, Ananda

AU - Ruffin, Mack

AU - Nease, Donald E.

AU - Gramling, Robert

AU - Acheson, Louise S.

AU - O'Neill, Suzanne M.

AU - Rubinstein, Wendy S.

PY - 2012/10/1

Y1 - 2012/10/1

N2 - Background: Family Healthware™, a tool developed by the CDC, is a self-administered web-based family history tool that assesses familial risk for six diseases (coronary heart disease; stroke; diabetes; and colon, breast, and ovarian cancers) and provides personalized prevention messages based on risk. The Family Healthware Impact Trial (FHITr) set out to examine the clinical utility of presenting personalized preventive messages tailored to family history risk for improving health behaviors. Purpose: The purpose of this study was to examine the impact of Family Healthware on modifying disease risk perceptions, particularly among those who initially underestimated their risk for certain diseases. Design: A total of 3786 patients were enrolled in a cluster-randomized trial to evaluate the clinical utility of Family Healthware. Setting/participants: Participants were recruited from 41 primary care practices among 13 states between 2005 and 2007. Main outcome measures: Perceived risk for each disease was assessed at baseline and 6-month follow-up using a single-item comparative risk question. Analyses were completed in March 2012. Results: Compared to controls, Family Healthware increased risk perceptions among those who underestimated their risk for heart disease (15% vs 9%, p<0.005); stroke (11% vs 8%, p<0.05); diabetes (18% vs 11%, p<0.05); and colon cancer (17% vs 10%, p=0.05) but not breast or ovarian cancers. The majority of underestimators did not shift in their disease risk perceptions. Conclusions: Family Healthware was effective at increasing disease risk perceptions, particularly for metabolic conditions, among those who underestimated their risk. Results from this study also demonstrate the relatively resistant nature of risk perceptions. Trial registration: This study is registered at clinicaltrials.gov NCT00164658.

AB - Background: Family Healthware™, a tool developed by the CDC, is a self-administered web-based family history tool that assesses familial risk for six diseases (coronary heart disease; stroke; diabetes; and colon, breast, and ovarian cancers) and provides personalized prevention messages based on risk. The Family Healthware Impact Trial (FHITr) set out to examine the clinical utility of presenting personalized preventive messages tailored to family history risk for improving health behaviors. Purpose: The purpose of this study was to examine the impact of Family Healthware on modifying disease risk perceptions, particularly among those who initially underestimated their risk for certain diseases. Design: A total of 3786 patients were enrolled in a cluster-randomized trial to evaluate the clinical utility of Family Healthware. Setting/participants: Participants were recruited from 41 primary care practices among 13 states between 2005 and 2007. Main outcome measures: Perceived risk for each disease was assessed at baseline and 6-month follow-up using a single-item comparative risk question. Analyses were completed in March 2012. Results: Compared to controls, Family Healthware increased risk perceptions among those who underestimated their risk for heart disease (15% vs 9%, p<0.005); stroke (11% vs 8%, p<0.05); diabetes (18% vs 11%, p<0.05); and colon cancer (17% vs 10%, p=0.05) but not breast or ovarian cancers. The majority of underestimators did not shift in their disease risk perceptions. Conclusions: Family Healthware was effective at increasing disease risk perceptions, particularly for metabolic conditions, among those who underestimated their risk. Results from this study also demonstrate the relatively resistant nature of risk perceptions. Trial registration: This study is registered at clinicaltrials.gov NCT00164658.

UR - http://www.scopus.com/inward/record.url?scp=84866435105&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866435105&partnerID=8YFLogxK

U2 - 10.1016/j.amepre.2012.06.013

DO - 10.1016/j.amepre.2012.06.013

M3 - Article

C2 - 22992357

AN - SCOPUS:84866435105

VL - 43

SP - 392

EP - 398

JO - American Journal of Preventive Medicine

JF - American Journal of Preventive Medicine

SN - 0749-3797

IS - 4

ER -